We are monitoring the impact of COVID-19 & Recession alarm on Europe Haemostatic Agents Market Get in touch with us for detailed analysis Know More

Know More

Share on

Europe Haemostatic Agents Market Research Report – Segmented By Type, Treatment, End User and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) – Industry Size, Share, Trends and Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 4373
Pages: 185

The size of the Haemostatic Agents Market in Europe is estimated to grow at a robust CAGR from 2022 to 2027.

The usage of advanced hemostasis medicines is becoming increasingly necessary as the number of patients suffering from bleeding disorders rises. Hemostasis agents will be in high demand due to the increase in surgical operations, surgical technique advances such as robot-assisted surgery, rising adoption of combination hemostats, rising frequency of chronic diseases among the aging population, which propels the market forward in Europe. An increase in the number of injuries caused by sports and road accidents is another key factor promoting the growth of the hemostatic agents market in the European region.

Geriatric individuals necessitate immediate attention and are prone to injuries and wounds that take a long time to cure. As the population shifts toward a more active lifestyle, the number of minor injuries and wounds is predicted to rise, fueling the market growth. Chronic disorders eventually lead to patients undergoing surgical operations, which accelerates their growth. Chronic illnesses that require these products include hernia repair, diabetes, spine injuries, ocular injuries and replacements, urological disorders, and burns.

The high cost of surgical treatments, as well as unfavorable reimbursement policies, may limit market expansion. Furthermore, in this nation, a lack of awareness and awareness about recent technological developments could restrict the growth of the European Hemostatic Agents market. Furthermore, the strict regulatory environment surrounding the approval of these sealing agents is a significant growth hurdle. In addition, the increased usage of off-label hemostat medicines is expected to restrict market growth. Another major stumbling block to growth is the expensive cost of tissue sealing agents.

This research report on the European haemostatic agents market has been segmented and sub-segmented into the following categories:

  • By Type: Thrombin Based Haemostats, Gelatin Based Haemostats, Collagen Based Haemostats, Oxidized Regenerated Cellulose Based Haemostats, Combination Haemostats, Fibrin Sealants, and Others
  • By Treatment: Cardiovascular, General Surgery, Digestive Surgery, Neurosurgery, and Others      
  • By End User: Hospitals, Surgery Centres, Nursing Homes, and Others      
  • By Country: United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, and Rest of Europe

Regionally, the European region has the second-highest market share globally, only behind the likes of North America, albeit with a low CAGR rate. The low growth rate of the region can be attributed to the fact that most countries in the region are at their pinnacle of development, and the room to grow is fast decreasing.

Furthermore, hospitals and clinics have increased their use of hemostats due to the rapid growth in other surgical procedures such as laparoscopy, knee and hip replacement surgeries, hernia operations, and the growing demand for minimally invasive procedures that offer less pain and faster recovery. The introduction of modern and new products such as FLOSEAL, TISEEL, and HEMOPATCH is projected to boost demand in Europe. The growing geriatric population is likely to fuel the regional market, resulting in a higher number of procedures. The strong marketing of such devices in the region is the main reason for the significant share. Other reasons driving growth include the growing use of such devices in surgeries and other medical applications and the desire for sealing agents that reduce post-operative problems and speed up recovery. The adoption of technologically improved products and the large volume of surgical procedures leading to a higher demand for the product are some of the causes that have led to the domination.

KEY MARKET PLAYERS:

Companies playing an influential role in the European haemostatic agents market profiled in this report are Ethicon, Pfizer, Baxter International, R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies, and Z-Medica.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Thrombin Based Haemostats          

                                5.1.3 Gelatin Based Haemostats               

                                5.1.4 Collagen Based Haemostats            

                                5.1.5 Oxidized Regenerated Cellulose Based Haemostats             

                                5.1.6 Combination Haemostats 

                                5.1.7 Fibrin Sealants       

                                5.1.8 Others      

                                5.1.9  Y-o-Y Growth Analysis, By Type    

                                5.1.10  Market Attractiveness Analysis, By Type                

                                5.1.11  Market Share Analysis, By Type  

                5.2 Treatment                  

                                5.2.1 Introduction           

                                5.2.2 Cardiovascular       

                                5.2.3 General Surgery   

                                5.2.4 Digestive Surgery 

                                5.2.5 Neurosurgery        

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Treatment          

                                5.2.8 Market Attractiveness Analysis, By Treatment        

                                5.2.9 Market Share Analysis, By Treatment         

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Surgery Centres    

                                5.3.4 Nursing Homes     

                                5.3.5 Others      

                                5.3.6 Y-o-Y Growth Analysis, By End User             

                                5.3.7  Market Attractiveness Analysis, By End User          

                                5.3.8  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Treatment

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Treatment

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Treatment

                                                6.1.5.4 By End User

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Ethicon                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer                            

                8.3 Baxter International                               

                8.4 R. Bard                          

                8.5 The Medicines Company                      

                8.6 Anika Therapeutics                 

                8.7 Advanced Medical Solutions                               

                8.8 Integra Life Sciences                               

                8.9 Gelita Medical                           

                8.10 Z-Medica                   

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Europe Haemostatic Agents Market, By Type, From 2022 - 2027 (USD Million)
  2. Europe Thrombin Based Market, By Region, From 2022 - 2027 (USD Million)
  3. Europe Gelatin Based Market, By Region, From 2022 - 2027 (USD Million)
  4. Europe Collagen Based Market, By Region, From 2022 - 2027 (USD Million)
  5. Europe Oxidized Regenerated Cellulose Based Market, By Region, From 2022 - 2027 (USD Million)
  6. Europe Combination Haemostats Market, By Region, From 2022 - 2027 (USD Million)
  7. Europe Fibrin Sealants Market, By Region, From 2022 - 2027 (USD Million)
  8. Europe Others Market, By Region, From 2022 - 2027 (USD Million)
  9. Europe Haemostatic Agents Market, By Treatment, From 2022 - 2027 (USD Million)
  10. Europe Cardiovascular Market, By Region, From 2022 - 2027 (USD Million)
  11. Europe General Surgery Market, By Region, From 2022 - 2027 (USD Million)
  12. Europe Digestive Surgery Market, By Region, From 2022 - 2027 (USD Million)
  13. Europe Neurosurgery Market, By Region, From 2022 - 2027 (USD Million)
  14. Europe Others Market, By Region, From 2022 - 2027 (USD Million)
  15. Europe Haemostatic Agents Market, By End Users, From 2022 - 2027 (USD Million)
  16. Europe Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  17. Europe Surgery Centres Market, By Region, From 2022 - 2027 (USD Million)
  18. Europe Nursing Homes Market, By Region, From 2022 - 2027 (USD Million)
  19. Europe Others Market, By Region, From 2022 - 2027 (USD Million)
  20. U.K. Haemostatic Agents Market, By Type, From 2022 - 2027 (USD Million)
  21. U.K. Haemostatic Agents Market, By Treatment, From 2022 - 2027 (USD Million)
  22. U.K. Haemostatic Agents Market, By End Users, From 2022 - 2027 (USD Million)
  23. Germany Haemostatic Agents Market, By Type, From 2022 - 2027 (USD Million)
  24. Germany Haemostatic Agents Market, By Treatment, From 2022 - 2027 (USD Million)
  25. Germany Haemostatic Agents Market, By End Users, From 2022 - 2027 (USD Million)
  26. France Haemostatic Agents Market, By Type, From 2022 - 2027 (USD Million)
  27. France Haemostatic Agents Market, By Treatment, From 2022 - 2027 (USD Million)
  28. France Haemostatic Agents Market, By End Users, From 2022 - 2027 (USD Million)
  29. Italy Haemostatic Agents Market, By Type, From 2022 - 2027 (USD Million)
  30. Italy Haemostatic Agents Market, By Treatment, From 2022 - 2027 (USD Million)
  31. Italy Haemostatic Agents Market, By End Users, From 2022 - 2027 (USD Million)
  32. Spain Haemostatic Agents Market, By Type, From 2022 - 2027 (USD Million)
  33. Spain Haemostatic Agents Market, By Treatment, From 2022 - 2027 (USD Million)
  34. Spain Haemostatic Agents Market, By End Users, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample